journal
MENU ▼
Read by QxMD icon Read
search

PET Clinics

journal
https://www.readbyqxmd.com/read/29482756/imaging-in-gynecologic-oncology
#1
EDITORIAL
Drew A Torigian, Domenico Rubello
No abstract text is available yet for this article.
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29482755/emerging-molecular-imaging-techniques-in-gynecologic-oncology
#2
REVIEW
Gigin Lin, Chyong-Huey Lai, Tzu-Chen Yen
Molecular imaging (mainly PET and MR imaging) has played important roles in gynecologic oncology. Emerging MR-based technologies, including DWI, CEST, DCE-MR imaging, MRS, and DNP, as well as FDG-PET and many novel PET radiotracers, will continuously improve practices. In combination with radiomics analysis, a new era of decision making in personalized medicine and precisely guided radiation treatment planning or real-time surgical interventions is being entered into, which will directly impact on patient survival...
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29482754/quantitative-assessment-of-gynecologic-malignancies
#3
REVIEW
Sarthak Tripathy, Girish Kumar Parida, Rakesh Kumar
18 F-fluorodeoxyglucose PET/CT as a dual-modality imaging, plays a key role in the diagnosis, staging, response assessment, and disease surveillance. Uptake by tumor cells offers an opportunity to differentiate viable malignant cells from posttreatment effects. 18 F-fluorodeoxyglucose PET/CT-based criteria have been developed to evaluate treatment response. Uptake can reflect the biologic aggressiveness of the tumor, predicting the risk of metastasis and recurrence. The standardized uptake value can be measured as maximum, mean, or peak...
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29482753/normal-variants-and-pitfalls-encountered-in-pet-assessment-of-gynecologic-malignancies
#4
REVIEW
Jian Q Yu, Mohan Doss, R Katherine Alpaugh
Combined PET/computed tomography is used for oncological indications. PET/computed tomography benefits from the metabolic information of PET and the anatomic localization of computed tomography. The integrated scanner provides data with accurate registration of anatomy and molecular information. Many physiologic conditions, normal variants, and benign lesions within the pelvis and the body can cause confusion and uncertainty. False-negative results owing to low 18 F-fluorodeoxyglucose uptake from the tumor can produce diagnostic challenges and inaccurate conclusions...
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29482752/non-18-f-2-fluoro-2-deoxy-d-glucose-pet-computed-tomography-in-gynecologic-oncology-an-overview-of-current-status-and-future-potential
#5
REVIEW
Ashwini Kalshetty, Sandip Basu
The current status and future potential targets of non-18 F-2-fluoro-2-deoxy-d-glucose (FDG) PET/computed tomography (CT) in 3 major gynecologic malignancies are discussed. Estrogen receptor-based 16alpha-18 F-fluoro-17beta-estradiol (18 F-FES) PET/CT has been investigated in (a) Uterine malignancies (both endometrial and myometrial pathologies) and (b) ovarian carcinoma. For uterine tumors, FDG/FES standardized uptake value and/or uptake ratio showed a positive correlation with malignant transformation (ie, endometrial carcinoma and uterine sarcoma) and higher malignant grades, whereas higher 18 F-FES uptake was documented in benign pathologies (ie, endometrial hyperplasia and leiomyoma)...
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29482751/the-role-of-pet-imaging-in-gynecologic-radiation-oncology
#6
REVIEW
Yuan James Rao, Perry W Grigsby
The goal of this review is to discuss the current utility of fluorine-18-fluorodeoxyglucose (FDG)-PET for radiation oncologists who treat gynecologic malignancies. FDG-PET/computed tomography (CT) is recommended for baseline assessment in cervical cancer and for staging in vulvar and vaginal cancer. The authors use FDG-PET/CT in definitive radiation treatment planning for cervical, vulvar, and vaginal cancer. PET may be helpful for salvage radiation treatment planning for any recurrent gynecologic malignancy...
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29482750/fdg-pet-assessment-of-other-gynecologic-cancers
#7
REVIEW
Silvana Faria, Catherine Devine, Chitra Viswanathan, Sanaz Javadi, Brinda Rao Korivi, Priya R Bhosale
PET and PET/computed tomography play a role in the staging, monitoring of response to therapy, and surveillance for cervical and ovarian cancers. Currently, it is also an integral part of the assessment of patients with endometrial cancer and other gynecologic malignancies, such as vaginal and vulvar cancers and uterine sarcomas. In this article, we discuss in detail and highlight the potential role of PET and PET/computed tomography in evaluating these gynecologic malignancies using illustrative cases with relevant imaging findings...
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29482749/fludeoxyglucose-f-18-pet-ct-assessment-of-ovarian-cancer
#8
REVIEW
Maria Cristina Marzola, Sotirios Chondrogiannis, Domenico Rubello
Ovarian cancer is one of the most common gynecologic cancers and one of the leading causes of cancer death in women. It is often asymptomatic in early stages, and thus most patients are diagnosed when it is of advanced stage. For these reasons, the role of biomarkers and tomographic imaging is crucial. Fludeoxyglucose F 18 PET/CT is a useful imaging modality in different clinical settings of the disease, overcoming some limits of conventional imaging and influencing prognosis and therapeutic approaches. PET/MR imaging is an emerging modality, and its potential role remains to be explored...
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29482748/-18f-2-fluoro-2-deoxy-d-glucose-pet-assessment-of-cervical-cancer
#9
REVIEW
Chitra Viswanathan, Silvana Faria, Catherine Devine, Madhavi Patnana, Tara Sagebiel, Revathy B Iyer, Priya R Bhosale
This article provides an overview of PET in cervical cancer, primarily with regard to the use of 18 F-2-fluoro-2-deoxy-d-glucose-PET/computed tomography. A brief discussion of upcoming technologies, such as PET/MR imaging, is presented.
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29482747/the-usefulness-of-ultrasound-imaging-in-gynecologic-oncology
#10
REVIEW
Courtney A Woodfield
Pelvic ultrasound examination is the primary imaging modality for evaluating a wide range of female pelvic symptomatology, and is often the first imaging test to detect a gynecologic malignancy. Ultrasound imaging is particularly useful for evaluating the thickness and appearance of the endometrium in patients with abnormal bleeding, and in detecting and characterizing ovarian lesions. This article reviews the ultrasound appearance of gynecologic neoplasms grouped by anatomic site of origin, the ultrasound appearance of select benign pelvic pathology not to be misinterpreted as malignancy, as well as available ultrasound imaging-based guidelines for managing potential gynecologic neoplasms...
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29482746/the-role-of-computed-tomography-and-magnetic-resonance-imaging-in-gynecologic-oncology
#11
REVIEW
Sherelle L Laifer-Narin, Wendy F Genestine, Nancy C Okechukwu, Elizabeth M Hecht, Jeffrey H Newhouse
This article discusses the role of Computed tomography (CT) and MR imaging in gynecologic malignancies by reviewing epidemiology, histologic subtypes, and staging systems. Imaging findings specific to different gynecologic malignancies on CT and MR imaging are reviewed and the advantages of each imaging modality discussed. Imaging of endometrial, cervical, and ovarian cancer is reviewed in depth, with a brief discussion of rare gynecologic cancers.
April 2018: PET Clinics
https://www.readbyqxmd.com/read/29157391/lung-cancer
#12
EDITORIAL
Gang Cheng, Tim Akhurst
No abstract text is available yet for this article.
January 2018: PET Clinics
https://www.readbyqxmd.com/read/29157390/practical-considerations-for-clinical-pet-mr-imaging
#13
REVIEW
Samuel Galgano, Zachary Viets, Kathryn Fowler, Lael Gore, John V Thomas, Michelle McNamara, Jonathan McConathy
Clinical PET/MR imaging is currently performed at a number of centers around the world as part of routine standard of care. This article focuses on issues and considerations for a clinical PET/MR imaging program, focusing on routine standard-of-care studies. Although local factors influence how clinical PET/MR imaging is implemented, the approaches and considerations described here intend to apply to most clinical programs. PET/MR imaging provides many more options than PET/computed tomography with diagnostic advantages for certain clinical applications but with added complexity...
January 2018: PET Clinics
https://www.readbyqxmd.com/read/29157389/improved-detection-of-small-pulmonary-nodules-through-simultaneous-mr-pet-imaging
#14
REVIEW
Fernando E Boada, Thomas Koesters, Kai Tobias Block, Hersh Chandarana
Magnetic resonance (MR)/PET scanners provide an imaging platform that enables simultaneous acquisition of MR and PET data in perfect spatial and temporal registration. This feature allows improving image quality for the MR and PET images obtained during the course of an examination. In this work the authors demonstrate the use of prospective MR-based motion tracking information for removing motion blur in MR/PET images of small pulmonary nodules. The theoretical basis for the algorithms is presented alongside clinical examples of its use...
January 2018: PET Clinics
https://www.readbyqxmd.com/read/29157388/future-directions-in-pet-imaging-of-lung-cancer
#15
REVIEW
Tim Akhurst
There is an ongoing and successful effort in developing new radiopharmaceuticals that coupled with new developments in chemistry and instrumentation offers the potential of rapidly defining imaging biomarkers and theranostic paradigms. The overarching challenge remains in funding and approving such agents; the Food and Drug Administration in the United States is making efforts to improve the process, but the time to release PET agents from the regulator shackles is surely now, to bring to patients the excellence of preclinical work that has already been done...
January 2018: PET Clinics
https://www.readbyqxmd.com/read/29157387/non-small-cell-lung-cancer-pet-imaging-beyond-f18-fluorodeoxyglucose
#16
REVIEW
Gang Cheng
F18 Flurodeoxyglucose (FDG) is a nonspecific PET tracer representing tumor energy metabolism, with common false-positive and false-negative findings in clinical practice. Non-small cell lung cancer is highly heterogeneous histologically, biologically, and molecularly. Novel PET tracers designed to characterize a specific aspect of tumor biology or a pathway-specific molecular target have the potential to provide noninvasive key information in tumor heterogeneity for patient stratification and in the assessment of treatment response...
January 2018: PET Clinics
https://www.readbyqxmd.com/read/29157386/prognostic-value-of-18-f-fluorodeoxyglucose-pet-computed-tomography-in-non-small-cell-lung-cancer
#17
REVIEW
Gang Cheng, He Huang
Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related death with a poor prognosis. Numerous factors contribute to treatment outcome. 18F-fluorodeoxyglucose (FDG) uptake reflects tumor metabolic activity and is an important prognosticator in patients with NSCLC. Volume-based FDG-PET parameters reflect the metabolic status of a malignancy more accurately than maximum standardized uptake value and thus are better prognostic markers in lung cancer. FDG-avid tumor burden parameters may help clinicians to predict treatment outcomes before and during therapy so that treatment can be adjusted to achieve the best possible outcomes while avoiding side effects...
January 2018: PET Clinics
https://www.readbyqxmd.com/read/29157385/treatment-planning-for-radiation-therapy
#18
REVIEW
Michael MacManus, Sarah Everitt
PET scanning plays key roles in planning the management of patients with lung cancer who are candidates for curative-intent treatment with radiotherapy and has contributed to improvements in survival. (18)F-fluorodeoxyglucose-PET is the most important modality for staging, patient selection, and radiotherapy target volume definition in patients with unresectable non-small cell lung cancer. Developments include the availability of alternative tracers, such as (18)F-fluorothymidine, for imaging proliferation and a range of hypoxia imaging agents...
January 2018: PET Clinics
https://www.readbyqxmd.com/read/29157384/genomic-characterization-of-lung-cancer-and-its-impact-on-the-use-and-timing-of-pet-in-therapeutic-response-assessment
#19
REVIEW
Lavinia Tan, Benjamin Solomon
Significant advances in understanding the genomic landscape of non-small cell lung cancer (NSCLC) together with the coupling discovery of key oncogenic drivers and the development of effective targeted and immunotherapeutic agents have revolutionized the management of this malignancy. Although these therapies have resulted in improved outcomes for a subgroup of patients, their benefit may not necessarily be reflected by conventional response assessment criteria, because these therapeutic agents differ in their mechanism of action and response time compared with cytotoxic chemotherapy...
January 2018: PET Clinics
https://www.readbyqxmd.com/read/29157383/18f-fluoro-2-deoxy-d-glucose-pet-computed-tomography-evaluation-of-lung-cancer-in-populations-with-high-prevalence-of-tuberculosis-and-other-granulomatous-disease
#20
REVIEW
Alexandre Niyonkuru, Khamis Hassan Bakari, Xiaoli Lan
Pulmonary tuberculosis infects one-third of world's population and is responsible for the high mortality and morbidity in developing countries. The presence of a high number of macrophages and lymphocytes in active tuberculosis granulomas is associated with high uptake of 18F-fluoro-2-deoxy-d-glucose on PET imaging mimicking lung cancer. In many cases, radiological features of pulmonary tuberculosis are undistinguishable from lung cancer, which makes the diagnosis difficult. Clinical history and computed tomographic (CT) findings on a hybrid PET/CT are as important as findings on a PET in the diagnosis of lung cancer...
January 2018: PET Clinics
journal
journal
41201
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"